Locametz 25 mcg (GALLIUM (68Ga) GOZETOTIDE KIT) 25 MCG

LOCAMETZ 25 MCG is a diagnostic kit containing Gallium (68Ga) Gozetotide, used for imaging purposes. This intravenous formulation is manufactured by Novartis Pharmaceuticals Canada Inc.

Strength

25 MCG

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LOCAMETZ 25 MCG is primarily used for diagnostic imaging. It helps in identifying and evaluating certain conditions by providing detailed images of the body. This kit is designed for intravenous administration and is intended for use in medical settings where imaging is required.

Side Effects

The effects of LOCAMETZ 25 MCG are typically observed through imaging results. It aids in visualizing specific areas of the body to assist in diagnosis. Common effects include improved imaging clarity, which can help healthcare professionals make informed decisions.

Precautions & Warnings

Handling LOCAMETZ 25 MCG requires careful attention to safety protocols. It should be administered by trained healthcare professionals in a controlled environment. Proper storage and disposal procedures must be followed to ensure safety.

Avoid Interactions

LOCAMETZ 25 MCG may interact with certain medications or substances. It is important to inform healthcare providers about all current medications before administration. Specific interactions should be discussed with a healthcare professional to avoid potential complications.

Frequently Asked Questions

LOCAMETZ 25 MCG is used for diagnostic imaging purposes, helping to visualize specific areas of the body.

LOCAMETZ 25 MCG is administered intravenously by trained healthcare professionals.

The common effects include improved imaging clarity, aiding in the diagnosis of certain conditions.

Yes, it should be handled and administered by trained professionals in a controlled environment.

Yes, it may interact with certain medications, so it's important to inform healthcare providers about all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.